Clinical characteristics and outcome of surgically treated severe hypercalcemia: Due to primary hyperparathyroidism;Características clínicas y evolución de la hipercalcemia grave por hiperparatiroidismo primario en pacientes intervenidos quirúrgicamente

Revista de Investigacion Clinica

Volumn 52, Issue 6, 2000, Pages 618-624

  Velázquez, David ^a   Gamino, Rosa ^a   Reza Albarrán, Alfredo ^b   Herrera, Miguel F ^a,b  

^a Departamento de Cirugía   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Hypercalcemia; Parathyroid glands; Primary hyperparathyroidism

Indexed keywords

BUMETANIDE; CALCITONIN DERIVATIVE; CALCIUM ION; CLODRONIC ACID; ETACRYNIC ACID; ETIDRONIC ACID; FUROSEMIDE; HYDROCORTISONE; MITHRAMYCIN; PAMIDRONIC ACID; PARATHYROID HORMONE; PROSTAGLANDIN E2;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; MALE; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SEVERITY OF ILLNESS INDEX;

EID: 18544393404     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Zinser JW, Rolla AR. Hiperparatiroidismo primario e hipercalcemia asociada a malignidad. En: Herrera MF, Lerman I, Rull JA, Campuzano M. (Eds.) Endocrinología. Controversias médico-quirúrgicas. (Cap. 27). Editorial McGraw-Hill-Interamericana, México, 1996: 131-4.
2. Correa-Rotter R, Kelber J. Crisis hipercalcémica. En: Herrera MF, Lerman I, Rull JA, Campuzano M. (Eds.) Controversias médico-quirúrgicas en Endocrinología. Cap. 28. Editorial McGraw-Hill-Interamericana, México, 1996: 135-7.
3. Mundy GR. Hypercalcemia associated with malignant tumors. De: Mazzaferri and Samaan. Endocrine tumors. Cap 36. Editorial Blackwell Scientific Publications, USA 1993: 567-91.
4. Aurbach GD, Marx S, Spiegel AM. Primary hyperparathyroidism. Parathyroid hormone, calcitonin and the calciferols. In: William M. William's textbook of endocrinology. Cap 27, Vol. I. Editorial Wilson and Foster. 8a edition, USA 1992: 1429-56.
5. Adlin VE. Disorders of the parathyroid glands. Endocrine and metabolic diseases. In: Myers A. The National Medical Series for independent study: Medicine. Cap. 9. Editorial Harwal Publishing, International edition, 1994: 418-21.
6. Wells SA. Hiperparatiroidismo e hipercalcemia. En: Sabiston and Lyerly. Tratado de patología quirúrgica. Tomo I. Cap. 23. Editorial Interamericana, México, 1994: 642-66.
7. Nussbaum SR. Pathophysiology and management of severe hypercalcemia. Endocrinology and Metabolism Clinics of North America. Endocrine Crisis 1993; 22(2): 343-61.
8. Obara T, Fujimoto Y. Diagnosis and treatment of patients with parathyroid carcinoma: An update and review. World J Surg 1991; 15: 738-44.
9. Edelson GW, Kleerokoper M. Hypercalcemic crisis. Med Clin North Am 1995; 79(1): 79-92.
10. Hehrmann R. Hypercalcemic crisis. Exacerbation of an existing hypercalcemia syndrome. Fortschr Med 1996; 114(10): 118-22.
11. López CR, Sainz JL, Russell C. Tratamiento quirúrgico del hiperparatiroidismo primario (adenoma). En: Herrera MF, Lerman I, Rull JA, Campuzano M. (Eds.) Controversias médico-quirúrgicas en Endocrinología. Cap. 30. Editorial McGraw-Hill, Interamericana, México, 1996: 143-8.
12. Chan AK, Duh QY, Katz MH, Siperstein AE, Clark OH. Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study. Ann Surgery 1995; 222(3): 402-14.
13. Irvin G, Sfakianakis G, Yeung L, Deriso G, Fishman L, Molinari A et al. Ambulatory parathyroidectomy for primary hyperparathyroidism. Arch Surg 1996; 131(10): 1074-8.
14. Tisell LE, Hedback G, Janssan S, Lindstedt G, Zachrisson BF. Management of hyperparathyroid patients with grave hypercalcemia. World J Surg 1991; 15: 730-7.
15. Christensen JH, Kristiansen JH. Combination therapy with pamidronate and calcitonin in hypercalcemic crisis caused by primary hyperparathyroidism. Ugeskr-Laeger 1996; 154(47): 3341-2.
16. Ljunghall B, Hellman P, Rastad F, Kerstrum G. Primary hyperparathyroidism: Epidemiology, diagnosis and clinical picture. World J Surg 1991; 15: 681-7.
17. Fenig J, O'Riordain DS. Tratamiento quirúrgico del hiperparatiroidismo primario (hiperplasia). En: Herrera MF, Lerman I, Rull JA, Campuzano M. (Eds.) Controversias médico-quirúrgicas en Endocrinología. Cap. 31. Editorial McGraw-Hill, Interamericana, Méico, 1996: 149-54.
18. Siclari F, Herrmann G, Dralle H. Acute hypercalcemic crisis after an open-heart operation. Ann Thorac Surg 1990; 50(5): 831-2.
19. Miller DL. Preoperative localization and interventional treatment of parathyroid tumors: When and how? World J Surg 1991; 15: 706-15.
20. Gurbuz AT, Peetz ME. Giant mediastinal parathyroid cyst: an unusual cause of hypercalcemic crisis-case report and review of the literature. Surgery 1996; 120(5): 795-800.
21. Ott SM. Calcimimetic-New drugs with the potential to control hyperparathyroidism (Editorial comment). J Clin Endocrin and Metab 1998; 83(4): 1080-2.
22. Collins MT, Skarulins MC, Bilezikian JP, Silverberg SJ, Spiegel AM et al. Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J Clin Endocrin Metab 1998; 83(4): 1083-8.
23. Nishimura K, Nozawa M, Hara T, Sonoda T, Oka T. A case of primary hyperparathyroidism associated with marked hypercalcemic crisis. Hinyokika Kiyo 1994: 40(8): 729-34.
24. Radomski J, Cohn H. Parathyroid glands. Endocrine disorders. In: Jarrell B, Carabasi A. The National Medical Series for independent study: Surgery. Cap V. Editorial Harval Publishing. International edition. 1996: 317-23.
25. Reza A, Wheeler MH. Hiperparatiroidismo primario asintomdtico. En: Herrera MF, Lerman I, Rull JA, Campuzano M. (Eds.) Controversias médico-quirúrgicas en Endocrinología. Cap. 29. Editorial McGraw-Hill, Interamericana, México, 1996: 138-42.
26. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999; 341(17): 1249-55.
27. Kebebew E, Clark OH. Parathyroid adenoma, hiperplasia and carcinoma: localization, technical details of primary neck exploration and treatment of hypercalcemic crisis. Surg Oncol Clin North Am 1998; 7(4): 721-48.
28. Sekine M, Takami H. Combination of calcitonin and pamidronate for emergency treatment of malignant hyperealcemia. Oncol Rep 1998; 5(1): 197-9.
29. Bradwell AR, Harvey TC. Control of hyperealcemia of parathyroid carcinoma by immunization. Comment. Lancet 1999; 353: 340.
30. Strewller GJ, Rosenblatt M. mineral metabolism hyperealcemia. En: Felig P, Baxter J, Frohman L. Endocrinology and metabolism. Cap 23. Editorial McGraw-Hill-International, 1995: 1407-1516.
31. van Heerden JA, Grant CS. Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg 1991; 15: 668-92.
32. Kobayashi T, Yokoyama K. An emergency operation for a patient in hypercalcemic crisis - a case report. Masui 1994; 43(5): 774-7.
33. Tisell LE, Hedbäck G, Jansson S, Lindstedt G, Zachrisson BF. Management of hyperparathyroid patients with grave hypercalcemia. World J Surg 1991; 15: 730-7.
34. Consensus development conference panel. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med 1991; 114: 593-7.